Skip to content

Immediate antipyretic effect of Hufu Copper Guasha on sepsis patients with exogenous fever: a randomized controlled trial

Immediate antipyretic effect of Hufu Copper Guasha on sepsis patients with exogenous fever: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003287
Enrollment
Unknown
Registered
2020-05-09
Start date
2020-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. aged between 18 and 70 years; 2. patients consistent with the diagnosis of sepsis and exogenous fever; 3. axillary temperature between 38.0 and 40.0 degrees C; 4. hyperthermia within 2 days; 5. sequential organ failure assessment (SOFA) <= 3 points; 6. patients sign the informed consent form voluntarily.

Exclusion criteria

Exclusion criteria: 1. pregnant and lactating women; 2. patients with central nervous fever; 3. patients with diabetes, malignancy or mental illness; 4. patients with coagulopathy; 5. patients with scar constitution and positive skin scratch test; 6. patients with A and B acute infectious diseases; 7. patients who have used other antipyretic drugs; 8. those with skin rashes, breakages, blisters, or ulcers on the surface of the Guasha area; 9. fever with convulsions, seizures, and closure.

Design outcomes

Primary

MeasureTime frame
body temperature (axillary temperature);

Secondary

MeasureTime frame
Interleukin 6 (IL-6);procalcitonin (PCT);tumor necrosis factor–a (TNF-a);C-reactive protein (CPR);white blood cell (WBC);

Countries

China

Contacts

Public ContactJingxia Zheng

Guangdong Provincial Hospital of Chinese Medicine

13622760199@126.com+86 13622760199

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026